期刊文献+

p-mTOR、GST-π和Ki-67在食管鳞状细胞癌中的表达及其相关性 被引量:6

Expression of p-mTOR,GST-π and Ki-67 in Human Esophageal Squamous Cell Carcinomas and Their Correlations
下载PDF
导出
摘要 目的研究p-mTOR、GST-π、Ki-67在食管鳞状细胞癌中的表达,并探讨三者表达水平的相关性和意义。方法运用免疫组织化学SP法检测88例不同分化程度的食管鳞状细胞中p-mTOR、GST-π和Ki-67的表达情况。结果p-mTOR、GST-π、Ki-67在食管高分化鳞癌中阳性表达率分别为20.8%、25%和62.5%,在中分化鳞癌中阳性表达率分别为39.1%、45.7%和65.4%,在低分化鳞癌中阳性表达率分别为66.7%、72.2%和94.4%。食管鳞癌组织中GST-π和p-mTOR表达水平具有相关性(rs=0.797,P<0.01),与Ki-67的表达水平则没有相关性(rs=0.126,P>0.05)。结论p-mTOR、GST-π和Ki-67的表达水平与食管鳞癌细胞的分化程度密切相关。GST-π表达水平与p-mTOR密切相关。p-mTOR阳性的食管鳞癌患者可能从p-mTOR活性抑制治疗中受益。 Objective To study the relationship of the expression of p-mTOR,GST-π and Ki-67 and their correlations in esophageal squamous cell carcinomas(ESCC). Methods The expression of p-mTOR,GST-π and Ki-67 was detected by SP immunohistochemical staining in ESCC. Results The positive expression rates of p-mTOR,GST-π and Ki-67 were 20.8%,25%,62.5% in well-differentiated group, 39.1%,45.7%,65.4% in moderately differentiated group and 66.7%,72.2%,94.4% in poorly differentiated group respectively. Significant correlation was found between the expression of p-mTOR and GST-π in ESCC(rs=0.797,P〈0.01), while no correlation was detected between p-mTOR and Ki-67(rs=0.126,P〉0.05). Conclusion The expressions of p-mTOR, GST-π and Ki-67 correlate significantly with ESCC differentiation.The expression level of GST-π correlates with p-mTOR significantly.Thus the subset of patients with p-mTOR positive may potentially benefit from p-mTOR inhibiting therapy.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第4期428-430,共3页 Cancer Research on Prevention and Treatment
关键词 MTOR GST-Π KI-67 免疫组织化学 mTOR GST-π Ki-67 Immunohistochemistry
  • 相关文献

参考文献7

  • 1Wu CP, Calcagno AM, Ambudkar SV. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: Evaluation of current strategies[J]. Curr Mol Pharmacol,2008, 1(2) :93-105.
  • 2陈爱军,刘文明,孟庆华,李祥.蛋白激酶C-α、CyclinD1和Cdk4在大肠癌中表达的相关性及临床意义[J].肿瘤防治研究,2008,35(1):27-29. 被引量:8
  • 3朱伦,陈增良.mTOR的结构与功能[J].国际病理科学与临床杂志,2006,26(1):31-34. 被引量:13
  • 4Chaisuparat R, Hu J, Jham BC, et al. Dual inhibition of PI3Kalpha and p-mTOR as an alternative treatment for Kaposrs sarcoma[J]. Cancer Res,2008,68(20):8361-8368.
  • 5Hou G, Xue L, Lu Z, et al. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR[J]. Cancer Lett, 2007, 253(2) :236-248.
  • 6Kim SG, Lee SJ. PI3K, RSK, and p-mTOR signal networks for the GST gene regulation[J]. Toxicol Sci,2007,96(2) :206- 213.
  • 7Boone J, Ten Kate FJ, Offerhaus G J, et al. mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular"therapy[J]. J Clin Pathol,2008, 61 (8) : 909-913.

二级参考文献20

  • 1KE-XIA YAN,BING-CI LIU,XIANG-LIN SHI,BAO-RONG YOU,MING XU.Role of CyclinD1 and CDK4 in the Carcinogenesis Induced by Silica[J].Biomedical and Environmental Sciences,2005,18(5):286-296. 被引量:14
  • 2Schmidt A, Bickle M, Beck T, et al. The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2[J]. Cell, 1997, 88(4) :531-542.
  • 3Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the fictor-mTOR complex [ J ]. Science,2005, 307(5712) :1098-1101.
  • 4Ali SM, Sabatini DM. Structure of S6 kinase 1 determines whether raptor-mTOR or rietor-mTOR phospharylates its hydrophobic motif site[J]. J Biol Chem, 2005, 280(20) :19445-19448.
  • 5Burnett PE, Barrow RK, Cohen NA, et al. BAFTI phosphorylation of the translational regulators pT0 S6 kinase and 4E-BP1 [ J ]. Proc Natl Acad Sci USA, 1998, 95(4) :1432-1437.
  • 6Pende M, Kozma SC, Jaquet M, et al. Hypoinsulinaemia, glucose intolerance and diminished beta-cell siza in S6K1-deficient mice[J]. Nature, 2000, 408(6815):994-997.
  • 7Gera JF, Mellinghoff IK, Shi Y, et al. AKT activity determines sensitivity to mammalian target of rapamycin(roTOR) inhibitors by regulating cyclin D1 and c-myc expression[J]. J Biol Chem, 2004, 279(4) :2737-2736.
  • 8Wullschleger S, Loewith R, Oppliger W, et al. Molecular organization of target of rapamycin complex 2 [ J ]. J Biol Chem, 2005, 280( 35 ) : 30697-30704.
  • 9Nissim H, Nahum S. Upstream and downstream of mTOR[ J]. Genes Dev, 2004, 18(16) :1926-1945.
  • 10Andrade M, Bork P. HEAT repeats in the Huntington's disease protein[J]. Nat Genet, 1995, 11(2):115-116.

共引文献19

同被引文献68

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部